Search all trials

Find therapies in clinical trials near you – page 296

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 955
countries: 28
conditions: 2 101

3 955 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Neuroendocrine tumour

Recruiting

Registered drugNo placebo

Study on the Effect of Octreotide and Lanreotide in Peptide Receptor Radionuclide Therapy for Adults with Neuroendocrine Tumors

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Adenocarcinoma pancreas+4

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of GTAEXS617 for Patients with Advanced Solid Tumors

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study on Immunotherapy with Atezolizumab, Tiragolumab, and Ipilimumab for Patients with Advanced Triple Negative Breast Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms

Investigational

Belgium

Participants:0–17 years
Substances:Risankizumab

Contact Research Centre

Aortic stenosis

Recruiting

Registered drugNo placebo

Study on Ticagrelor and Aspirin for Patients with Severe Aortic Stenosis After Heart Valve Replacement

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Glycogen storage disease type II

Recruiting

Registered drugNo placebo

Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Avalglucosidase Alfa

Contact Research Centre

Major depression

Recruiting

Registered drugNo placebo

Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

Registered drugNo placebo

Austria

Participants:18–64 years
Substances:Agomelatine

Contact Research Centre

Gastrooesophageal cancer+1

Recruiting

Registered drugNo placebo

Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Atrial fibrillation+2

Recruiting

Registered drug

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

ABO haemolytic disease of newborn

Recruiting

Investigational

Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Investigational

Austria

Participants:18–64 years
Substances:Nipocalimab

Contact Research Centre

Endometriosis

Recruiting

Registered drug

Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

Registered drug

The Netherlands

Participants:18–64 years
Substances:Ondansetron

Contact Research Centre

Axial spondyloarthritis

Recruiting

InvestigationalNo placebo

Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Technetium (99Mtc) Certolizumab Pegol

Contact Research Centre

Find therapies in clinical trials near you – page 296

3 955 trials match your criteria

Neuroendocrine tumour

Study on the Effect of Octreotide and Lanreotide in Peptide Receptor Radionuclide Therapy for Adults with Neuroendocrine Tumors

Adenocarcinoma pancreas+4

Study on the Safety and Effectiveness of GTAEXS617 for Patients with Advanced Solid Tumors

Triple negative breast cancer

Study on Immunotherapy with Atezolizumab, Tiragolumab, and Ipilimumab for Patients with Advanced Triple Negative Breast Cancer

Crohn's disease

Study on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms

Aortic stenosis

Study on Ticagrelor and Aspirin for Patients with Severe Aortic Stenosis After Heart Valve Replacement

Glycogen storage disease type II

Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

Major depression

Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

Gastrooesophageal cancer+1

Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

Atrial fibrillation+2

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

ABO haemolytic disease of newborn

Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Endometriosis

Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

Axial spondyloarthritis

Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.